Author Archives for Adeline Chauvigné

Xenothera news

XENOTHERA, created in 2014, is a Nantes-based biotech company which develops “humanized” polyclonal antibodies. Their technological platform is based on... View Article

Rédigé par Adeline Chauvigné, le 2020-05-15

Xenothera news

1 July 2025

XENOTHERA, created in 2014, is a Nantes-based biotech company which develops “humanized” polyclonal antibodies. Their technological platform is based on... View Article

GlioCure finalises its seed capital with a financing from « French Tech Seed » and reports a second consecutive profitable year

1 July 2025

Angers, May 12th, 2020 – GlioCure SAS, a biotech company specialised in neuro-oncology, held its ordinary Annual General Meeting, and... View Article

ENEN+ PROJECT

1 July 2025

Attract, Retain and Develop New Nuclear Talents beyond Academic Curricula The ENEN+ project, co-funded by the EURATOM research and training... View Article

OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program

1 July 2025

OSE Immunotherapeutics announced that the Company is committed to the fight against COVID-19. Its team of immunologists is actively working... View Article

Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15

1 July 2025

Phase 2 vaccine candidate, VLA15, is being evaluated for adult and pediatric indications in North America and Europe. Saint Herblain... View Article

Rare Diseases Research Challenges Call for proposals

1 July 2025

The French Foundation for Rare Diseases, partner of the European Joint Programme for Rare Diseases EJPRD, is pleased to announce... View Article

New member | Restaart

1 July 2025

Restaart laboratories offer a unique and ingenious multisensory experience that refuels our energy levels through short, fully guided, recovery sessions.... View Article

#Coronavirus | Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19

1 July 2025

Valneva is leveraging its technical and platform capabilities to develop an inactivated, whole virus vaccine candidate against the current coronavirus... View Article

#Coronavirus | Eurofins Medical Device Testing commitment to support the safety and efficacy of devices used in the COVID-19 Crisis Response

1 July 2025

NEWS PROVIDED BY Eurofins Medical Device Testing  COVID-19 pandemic emergency is putting health care systems under severe strain, reflecting an... View Article

New member | CENTICH – VyV Group

1 July 2025

The CENTICH is a private, non-profit organization, member of the French mutuality and the VyV group. It was created on... View Article